(University of Texas M. D. Anderson Cancer Center) The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

Related Links:

Over the last two or three decades, the pace of development of treatments for osteosarcoma tends has been slow. Novel effective therapies for osteosarcoma are still lacking. Previously, we reported that tumor-…

Source: Journal of Experimental and Clinical Cancer ResearchCategory: Cancer & Oncology Authors: Tags: Research Source Type: research

Authors: Xiao B, Huang Z, Zhou R, Zhang J, Yu B
Abstract
BACKGROUND The long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) is expressed in solid malignant tumors. The aim of this systematic review and meta-analysis was to determine whether expression of the lncRNA SNHG1 was associated with prognosis in patients with malignancy. MATERIAL AND METHODS A literature review from Jan 1970 to July 2018 identified publications in the English language. Databases searched included: PubMed, OVID, Web of Science, the Cochrane Database, Embase, EBSCO, Google Scholar. Systematic review and meta-analysis were per…

ma G. Nikalje

The work reports the facile synthesis of novel α-aminophosphonate derivatives coupled with indole-2,3-dione moieties, namely the diethyl(substituted phenyl/heteroaryl)(2-(2-oxoindolin-3-ylidene)hydrazinyl)methylphosphonates derivatives 4(a–n). One-pot three component Kabachnik-Fields reactions were used to synthesize these derivatives. The reaction was carried out at room temperature by stirring in presence of ceric ammonium nitrate (CAN) as a green catalyst. The structures of the synthesized compounds were established by spectral studies. The synthesized derivatives 4(a–n) w…

Source: MoleculesCategory: Chemistry Authors: Tags: Article Source Type: research

DiscussionThis was partly due to the fact that MSCs showed a potential to support tumor development. Moreover, the expression of mbTRAIL did not show caspase activation in adjacent tumor cells.

Source: CytotherapyCategory: Cytology Source Type: research

This study provides insight into the molecular mechanism of miR-323a-3p in regulating OS.

Source: Human CellCategory: Cytology Source Type: research

MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Oncol Rep. 2018 Jul 26;:
Authors: Chen Y, Huang T, Yang X, Liu C, Li P, Wang Z, Zhi S
Abstract
MicroRNAs (miRs) serve an essential role in tumorigenesis and are able to act as tumor suppressor genes or oncogenes. miR‑106a has been identified generally as an oncogene in multiple types of human cancer; however, its association with osteosarcoma has not previously been understood. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect miR‑106a expression in 18 …

Source: Oncology ReportsCategory: Cancer & Oncology Tags: Oncol Rep Source Type: research

ConclusionsSNHG1 represents promising novel biomarkers for various cancer types and have a great potential to be effectively used in clinical practice in the near future.

Conditions:   High Grade Ovarian Serous Adenocarcinoma;   Oligometastasis;   Ovarian Carcinosarcoma;   Pancreatic Ductal Adenocarcinoma;   Recurrent Malignant Neoplasm;   Recurrent Osteosarcoma;   Recurrent Ovarian Carcinoma;   Refractory Malignant Neoplasm;   Refractory Osteosarcoma;   Refractory Ovarian Carcinoma Interventions:   Biological: Autologous Tumor Infiltrating Lymphocytes MDA-TIL;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: In…

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

ConclusionWe have demonstrated a liquid biopsy-based approach for tracking cancer transcriptomic alterations, which is a promising source of prognostic and therapeutic biomarkers for metastatic OS.Clinical Trial RegistrationNCT03108677.

CONCLUSION: Health care delay among patients with a previous diagnosis was longer, and was probably associated with the time taken for to referral to cancer centers. Patients without a previous histopathological diagnosis had longer hospital delays, which could be associated with possible difficulties regarding demand and high-cost procedures. Despite limitations, this study helps provide initial knowledge about the healthcare pathway delays for patients with bone cancer inside several Brazilian hospitals.
PMID: 30075119 [PubMed – as supplied by publisher]

Source: Jornal de PediatriaCategory: Pediatrics Authors: Tags: J Pediatr (Rio J) Source Type: research





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Enter Captcha Here : *

Reload Image